DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
New York, NY
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| OrbiMed Private Investments IX LP | 2022 | Active deployment | n/a | n/a | 1 |
| OrbiMed Private Investments VIII LP | 2020 | Mature | n/a | n/a | 1 |
| OrbiMed Private Investments VI | 2015 | Harvest | n/a | n/a | 1 |
| OrbiMed Private Investments V | 2013 | Harvest | n/a | n/a | 2 |
| Orbimed Israel Partners Limited Partnership | 2011 | Harvest | $190M | $54.4M | 0 |
| Orbimed Private Investments IV, LP | 2009 | Harvest | $312M | $101M | 2 |
| Orbimed Asia Partners, L.P. | 2008 | Harvest | $172M | $88.5M | 0 |
| Orbimed Private Investments II, LP | n/a | Wound down | n/a | $28.0M | 0 |
| Orbimed Private Investments II (qp), LP | n/a | Wound down | n/a | $10.0M | 0 |
| Orbimed Private Investments, LP | n/a | Wound down | n/a | $5.5M | 0 |
| Orbimed Associates III, LP | n/a | Wound down | n/a | $1.5M | 0 |
| Orbimed Private Investments III, LP | n/a | Wound down | n/a | $75.2M | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Koya | n/a | n/a | n/a | n/a | Unknown | Sep 17, 2026 |
| world | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Telios Pharma Inc | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Cookiedatabase | n/a | n/a | n/a | n/a | Unknown | Sep 12, 2026 |
| Accro Bioscience | n/a | Series c | $50.0M | n/a | Unknown | May 18, 2026 |
| Vivacta Bio | n/a | Series a | $50.0M | n/a | Unknown | Apr 29, 2026 |
| Pulnovo Medical | n/a | unknown | $100M | n/a | Unknown | Apr 19, 2026 |
| Aspen Neuroscience | n/a | Series c | $115M | n/a | Unknown | Nov 20, 2025 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| OrbiMed | Omega Venture Partners | 1 | 1 | Sep 13, 2026 | One time |
| OrbiMed | York Investments Holdings, LLC | 1 | 1 | Sep 13, 2026 | One time |
| OrbiMed | Cota Capital Management, LLC | 1 | 1 | Sep 13, 2026 | One time |
| Plexo Capital Management, LLC | OrbiMed | 1 | 1 | Sep 12, 2026 | One time |
| NTI Managers, LLC | OrbiMed | 1 | 1 | Sep 12, 2026 | One time |
| Rice Park Capital | OrbiMed | 1 | 1 | Sep 12, 2026 | One time |
| Arboretum Ventures | OrbiMed | 1 | 1 | Sep 12, 2026 | One time |
| OrbiMed | SUN Mountain Capital Advisors, LLC | 1 | 1 | Sep 12, 2026 | One time |
| OrbiMed | Kite | 1 | 1 | Nov 20, 2025 | One time |
| OrbiMed | LYFE Capital | 1 | 1 | Nov 20, 2025 | One time |
| OrbiMed | Axon Ventures | 1 | 1 | Nov 20, 2025 | One time |
| OrbiMed | Loyal Valley Capital | 1 | 1 | Apr 29, 2026 | One time |
| OrbiMed | Tcgx | 1 | 1 | May 18, 2026 | One time |
| OrbiMed | Rockwood Equity Partners LLC | 1 | 1 | Sep 14, 2026 | One time |
| OrbiMed | Oriza Holdings | 1 | 1 | May 18, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Charles Scotland Stevens (Member), Peter Armstrong Thompson (Member), Douglas W. Coon (Chief Compliance Officer), Alexander Matthew Cooper (General Counsel), Geoffrey Che-Chang Hsu (Member), William Carter Neild (Member), Carl Lee Gordon (Member), Sven Heinz Borho (Member), SAM Block III (Chief Financial Officer), David Paul Bonita (Member), Matthew Scott Rizzo (Member).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan